Antagonists selective for estrogen receptor α

Jun Sun, Ying R. Huang, William R. Harrington, Shubin Sheng, John A. Katzenellenbogen, Benita S. Katzenellenbogen

Research output: Contribution to journalArticle

Abstract

To develop compounds that are antagonists on ERα, but not ERβ, we have added basic side-chains typically found in non-steroidal antiestrogens to pyrazole compounds that bind with much higher affinity to ERα than to ERβ. In this way we have developed basic side-chain pyrazoles (BSC-pyrazoles) that are high affinity, potent, selective antagonists on ERα. These BSC-pyrazoles are themselves inactive on ERα and ERβ, and they antagonize E2 stimulation by ERα only. We investigated seven basic side-chain substituents on various alkyl-triaryl-substituted pyrazoles, and the most ERα-selective compound was methyl-piperidino-pyrazole (MPP). ERα-selective antagonism was observed on diverse reporter-promoter gene constructs containing estrogen response elements that are consensus, nonconsensus (pS2), or comprised of multiple half-estrogen response elements (NHERF/EBP50) and on genes in which ER works indirectly by tethering to other DNA-bound proteins (TGFβ3). In contrast to these BSC-pyrazoles, the antiestrogens trans-hydroxytamoxifen, raloxifene, and ICI 182,780 suppress E2 activity via both ERα and ERβ. The most effective BSC-pyrazole, MPP, fully antagonized E2 stimulation of pS2 mRNA in MCF-7 breast cancer cells, consistent with the fact that these cells contain almost exclusively ERα. These compounds should be useful in studying the biological functions of ERα and ERβ and in selectively blocking responses that are mediated through ERα.

Original languageEnglish (US)
Pages (from-to)941-947
Number of pages7
JournalEndocrinology
Volume143
Issue number3
DOIs
StatePublished - Jan 1 2002

Fingerprint

Pyrazoles
Estrogen Receptor Modulators
Response Elements
Estrogens
Reporter Genes
Estrogen Receptor Antagonists
Breast Neoplasms
Messenger RNA
DNA
Genes
pyrazole
Proteins

ASJC Scopus subject areas

  • Endocrinology

Cite this

Sun, J., Huang, Y. R., Harrington, W. R., Sheng, S., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2002). Antagonists selective for estrogen receptor α. Endocrinology, 143(3), 941-947. https://doi.org/10.1210/endo.143.3.8704

Antagonists selective for estrogen receptor α. / Sun, Jun; Huang, Ying R.; Harrington, William R.; Sheng, Shubin; Katzenellenbogen, John A.; Katzenellenbogen, Benita S.

In: Endocrinology, Vol. 143, No. 3, 01.01.2002, p. 941-947.

Research output: Contribution to journalArticle

Sun, J, Huang, YR, Harrington, WR, Sheng, S, Katzenellenbogen, JA & Katzenellenbogen, BS 2002, 'Antagonists selective for estrogen receptor α', Endocrinology, vol. 143, no. 3, pp. 941-947. https://doi.org/10.1210/endo.143.3.8704
Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS. Antagonists selective for estrogen receptor α. Endocrinology. 2002 Jan 1;143(3):941-947. https://doi.org/10.1210/endo.143.3.8704
Sun, Jun ; Huang, Ying R. ; Harrington, William R. ; Sheng, Shubin ; Katzenellenbogen, John A. ; Katzenellenbogen, Benita S. / Antagonists selective for estrogen receptor α. In: Endocrinology. 2002 ; Vol. 143, No. 3. pp. 941-947.
@article{0f2c90f347a94d86b2b461a0e018f69d,
title = "Antagonists selective for estrogen receptor α",
abstract = "To develop compounds that are antagonists on ERα, but not ERβ, we have added basic side-chains typically found in non-steroidal antiestrogens to pyrazole compounds that bind with much higher affinity to ERα than to ERβ. In this way we have developed basic side-chain pyrazoles (BSC-pyrazoles) that are high affinity, potent, selective antagonists on ERα. These BSC-pyrazoles are themselves inactive on ERα and ERβ, and they antagonize E2 stimulation by ERα only. We investigated seven basic side-chain substituents on various alkyl-triaryl-substituted pyrazoles, and the most ERα-selective compound was methyl-piperidino-pyrazole (MPP). ERα-selective antagonism was observed on diverse reporter-promoter gene constructs containing estrogen response elements that are consensus, nonconsensus (pS2), or comprised of multiple half-estrogen response elements (NHERF/EBP50) and on genes in which ER works indirectly by tethering to other DNA-bound proteins (TGFβ3). In contrast to these BSC-pyrazoles, the antiestrogens trans-hydroxytamoxifen, raloxifene, and ICI 182,780 suppress E2 activity via both ERα and ERβ. The most effective BSC-pyrazole, MPP, fully antagonized E2 stimulation of pS2 mRNA in MCF-7 breast cancer cells, consistent with the fact that these cells contain almost exclusively ERα. These compounds should be useful in studying the biological functions of ERα and ERβ and in selectively blocking responses that are mediated through ERα.",
author = "Jun Sun and Huang, {Ying R.} and Harrington, {William R.} and Shubin Sheng and Katzenellenbogen, {John A.} and Katzenellenbogen, {Benita S.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1210/endo.143.3.8704",
language = "English (US)",
volume = "143",
pages = "941--947",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Antagonists selective for estrogen receptor α

AU - Sun, Jun

AU - Huang, Ying R.

AU - Harrington, William R.

AU - Sheng, Shubin

AU - Katzenellenbogen, John A.

AU - Katzenellenbogen, Benita S.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - To develop compounds that are antagonists on ERα, but not ERβ, we have added basic side-chains typically found in non-steroidal antiestrogens to pyrazole compounds that bind with much higher affinity to ERα than to ERβ. In this way we have developed basic side-chain pyrazoles (BSC-pyrazoles) that are high affinity, potent, selective antagonists on ERα. These BSC-pyrazoles are themselves inactive on ERα and ERβ, and they antagonize E2 stimulation by ERα only. We investigated seven basic side-chain substituents on various alkyl-triaryl-substituted pyrazoles, and the most ERα-selective compound was methyl-piperidino-pyrazole (MPP). ERα-selective antagonism was observed on diverse reporter-promoter gene constructs containing estrogen response elements that are consensus, nonconsensus (pS2), or comprised of multiple half-estrogen response elements (NHERF/EBP50) and on genes in which ER works indirectly by tethering to other DNA-bound proteins (TGFβ3). In contrast to these BSC-pyrazoles, the antiestrogens trans-hydroxytamoxifen, raloxifene, and ICI 182,780 suppress E2 activity via both ERα and ERβ. The most effective BSC-pyrazole, MPP, fully antagonized E2 stimulation of pS2 mRNA in MCF-7 breast cancer cells, consistent with the fact that these cells contain almost exclusively ERα. These compounds should be useful in studying the biological functions of ERα and ERβ and in selectively blocking responses that are mediated through ERα.

AB - To develop compounds that are antagonists on ERα, but not ERβ, we have added basic side-chains typically found in non-steroidal antiestrogens to pyrazole compounds that bind with much higher affinity to ERα than to ERβ. In this way we have developed basic side-chain pyrazoles (BSC-pyrazoles) that are high affinity, potent, selective antagonists on ERα. These BSC-pyrazoles are themselves inactive on ERα and ERβ, and they antagonize E2 stimulation by ERα only. We investigated seven basic side-chain substituents on various alkyl-triaryl-substituted pyrazoles, and the most ERα-selective compound was methyl-piperidino-pyrazole (MPP). ERα-selective antagonism was observed on diverse reporter-promoter gene constructs containing estrogen response elements that are consensus, nonconsensus (pS2), or comprised of multiple half-estrogen response elements (NHERF/EBP50) and on genes in which ER works indirectly by tethering to other DNA-bound proteins (TGFβ3). In contrast to these BSC-pyrazoles, the antiestrogens trans-hydroxytamoxifen, raloxifene, and ICI 182,780 suppress E2 activity via both ERα and ERβ. The most effective BSC-pyrazole, MPP, fully antagonized E2 stimulation of pS2 mRNA in MCF-7 breast cancer cells, consistent with the fact that these cells contain almost exclusively ERα. These compounds should be useful in studying the biological functions of ERα and ERβ and in selectively blocking responses that are mediated through ERα.

UR - http://www.scopus.com/inward/record.url?scp=0036177151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036177151&partnerID=8YFLogxK

U2 - 10.1210/endo.143.3.8704

DO - 10.1210/endo.143.3.8704

M3 - Article

C2 - 11861516

AN - SCOPUS:0036177151

VL - 143

SP - 941

EP - 947

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 3

ER -